| abstract |
[PROBLEMS] Treatment or prevention of pathological conditions involving uric acid such as hyperuricemia, gouty nodule, acute gouty arthritis, chronic gouty arthritis, gout kidney, urolithiasis, renal dysfunction, coronary artery disease, ischemic heart disease, etc. And the like, and a pharmaceutical composition excellent in stability over time and dissolution (disintegration). The pharmaceutical composition of the present invention contains a nitrogen-containing fused ring compound represented by the following general formula [1] or a pharmaceutically acceptable salt thereof, and one or more pharmaceutically acceptable additives. A pharmaceutical composition, wherein the nitrogen-containing fused ring compound or a pharmaceutically acceptable salt thereof does not come into contact with a basic additive. (In the formula, each symbol is as described in the specification.) [Selection figure] None |